GS/MS SF v. CVP SF for Healthcare Investment Banking?
Was wondering if anyone could provide insights on BB (GS/MS) vs. CVP for Healthcare IB in SF. Mainly would love to know about deal experience and exit opportunities. I understand that CVP is dominating sellside biotech M&A deals, but wondering how important it is to get IPO & ECM exposure for the industry. Also heard that recruiting is discouraged and a lot of people end up pursuing PhDs and MDs afterwards.
Dicta nam aspernatur qui animi. Adipisci occaecati cum cum delectus eius consectetur.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...